Breast Cancer Clinical Trial
Official title:
Prehabilitation Program Based on Health Education and Nordic Walking to Reduce Musculoskeletal Impairments in Women Undergoing Breast Cancer Surgery
Prehabilitation for women diagnosed with breast cancer is commonly not part of the clinical pathways as little time (usually a few days) is left between diagnosis and surgery. However, a great proportion of these patients will undergo neoadjuvant chemotherapy which provides a window opportunity to improve patients' physical status to withstand surgery and minimize post-operative musculoskeletal complications associated with surgery. To this end, the aim of this study is to assess the efficacy of a prehabilitation program consisting of health education and a supervised nordic walking-based intervention in women diagnosed with breast cancer currently undergoing neoadjuvant chemotherapy to decrease post-operative musculoskeletal impairments and improve functionality of the affected arm. The study is an open-label, single-blind randomised controlled trial conducted at one tertiary hospital. Women diagnosed with breast cancer scheduled for surgery and currently undergoing chemotherapy will be randomised to either usual care (UC) or prehabilitation (PREHAB). Patients will be assessed for eligibility during the fourth out of six course of chemotherapy. Those randomised to the PREHAB group will participate in a supervised group-based nordic walking intervention twice weekly during 8 weeks (approximately 16 sessions). In addition, participants will receive written information regarding the benefits of exercise during cancer treatment and surveillance. Patients will be assessed prior to surgery as well as at 1, 3 and 6 months postoperatively.
| Status | Recruiting |
| Enrollment | 64 |
| Est. completion date | November 1, 2023 |
| Est. primary completion date | October 1, 2023 |
| Accepts healthy volunteers | No |
| Gender | Female |
| Age group | 18 Years to 75 Years |
| Eligibility | Inclusion Criteria: - Diagnosis of breast cancer scheduled for surgery with or without lymphadenectomy - Candidates to receive neoadjuvant chemotherapy - Not currently undergoing any other physical therapy therapies or treatments Exclusion Criteria: - Cognitive impairment or inability to read Catalan or Spanish - Prior diagnosis of shoulder impairment or injury - Major musculoskeletal, neurological or cardiorespiratory limitations to prevent participation in the exercise program |
| Country | Name | City | State |
|---|---|---|---|
| Spain | Hospital Santa Creu i Sant Pau | Barcelona |
| Lead Sponsor | Collaborator |
|---|---|
| Raquel Sebio | Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau |
Spain,
ILokapavani Y, Krishna SR, Madhavi K. nfluence of Pre - Operative Physical Therapy Education and Exercise on Post-operative Shoulder Range of Motion and Functional Activites in Subjects with Modified Radical Mastectomy. Int J Physiother 2014. DOI: 10.15621/ijphy/2014/v1i4/54556
McNeely ML, Campbell KL, Rowe BH, Klassen TP, Mackey JR, Courneya KS. Effects of exercise on breast cancer patients and survivors: a systematic review and meta-analysis. CMAJ. 2006 Jul 4;175(1):34-41. doi: 10.1503/cmaj.051073. — View Citation
Santa Mina D, Brahmbhatt P, Lopez C, Baima J, Gillis C, Trachtenberg L, Silver JK. The Case for Prehabilitation Prior to Breast Cancer Treatment. PM R. 2017 Sep;9(9S2):S305-S316. doi: 10.1016/j.pmrj.2017.08.402. — View Citation
Silver JK, Baima J. Cancer prehabilitation: an opportunity to decrease treatment-related morbidity, increase cancer treatment options, and improve physical and psychological health outcomes. Am J Phys Med Rehabil. 2013 Aug;92(8):715-27. doi: 10.1097/PHM.0b013e31829b4afe. — View Citation
Yang A, Sokolof J, Gulati A. The effect of preoperative exercise on upper extremity recovery following breast cancer surgery: a systematic review. Int J Rehabil Res. 2018 Sep;41(3):189-196. doi: 10.1097/MRR.0000000000000288. — View Citation
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Disabilities of the Arm Shoulder and Hand Questionnaire (Quick DASH) | Functionality of the affected upper arm using the DASH questionnaire. The questionnaire compromises 11 items. Scoring ranges from 0 (no disability) to 100 (more severe disability) | Pre-Surgery (one week) | |
| Primary | Disabilities of the Arm Shoulder and Hand Questionnaire (Quick DASH) | Functionality of the affected upper arm using the DASH questionnaire. The questionnaire compromises 11 items. Scoring ranges from 0 (no disability) to 100 (more severe disability) | One month post-surgery | |
| Primary | Disabilities of the Arm Shoulder and Hand Questionnaire (Quick DASH) | Functionality of the affected upper arm using the DASH questionnaire. The questionnaire compromises 11 items. Scoring ranges from 0 (no disability) to 100 (more severe disability) | Three months post-surgery | |
| Primary | Disabilities of the Arm Shoulder and Hand Questionnaire (Quick DASH) | Functionality of the affected upper arm using the DASH questionnaire. The questionnaire compromises 11 items. Scoring ranges from 0 (no disability) to 100 (more severe disability) | Six months post-surgery | |
| Secondary | Upper arm volume | Perimeter of the affected arm will be measured with a tape measure at hand, wrist, elbow and shoulder level | Pre-Surgery (one week) | |
| Secondary | Upper arm volume | Perimeter of the affected arm will be measured with a tape measure at hand, wrist, elbow and shoulder level | One month post-surgery | |
| Secondary | Upper arm volume | Perimeter of the affected arm will be measured with a tape measure at hand, wrist, elbow and shoulder level | Three months post-surgery | |
| Secondary | Upper arm volume | Perimeter of the affected arm will be measured with a tape measure at hand, wrist, elbow and shoulder level | Six months post-surgery | |
| Secondary | Range of Movement (ROM) | Range of movement of the affected arm in three axes using a goniometer | Pre-Surgery (one week) | |
| Secondary | Range of Movement (ROM) | Range of movement of the affected arm in three axes using a goniometer | One month post-surgery | |
| Secondary | Range of Movement (ROM) | Range of movement of the affected arm in three axes using a goniometer | Three months post-surgery | |
| Secondary | Range of Movement (ROM) | Range of movement of the affected arm in three axes using a goniometer | Six months post-surgery | |
| Secondary | Pain severity | Global pain assessed with a Visual Analog Scale (0 no pain to 10 maximum pain) | Pre-Surgery (one week) | |
| Secondary | Pain severity | Global pain assessed with a Visual Analog Scale (0 no pain to 10 maximum pain) | One month post-surgery | |
| Secondary | Pain severity | Global pain assessed with a Visual Analog Scale (0 no pain to 10 maximum pain) | Three months post-surgery | |
| Secondary | Pain severity | Global pain assessed with a Visual Analog Scale (0 no pain to 10 maximum pain) | Six months post-surgery | |
| Secondary | Health-Related Quality of Life | Health-Related Quality of Life will be assessed with the questionnaire developed by the European Organization for Research and Treatment (EORTC) Quality of Life (QLQ) questionnaire (EORTC QLQ C30). Scores range from 0 to 100 with higher values associated with better overall quality of life | Pre-Surgery (one week) | |
| Secondary | Health-Related Quality of Life | Health-Related Quality of Life will be assessed with the questionnaire developed by the European Organization for Research and Treatment (EORTC) Quality of Life (QLQ) questionnaire (EORTC QLQ C30). Scores range from 0 to 100 with higher values associated with better overall quality of life | One month post-surgery | |
| Secondary | Health-Related Quality of Life | HHealth-Related Quality of Life will be assessed with the questionnaire developed by the European Organization for Research and Treatment (EORTC) Quality of Life (QLQ) questionnaire (EORTC QLQ C30). Scores range from 0 to 100 with higher values associated with better overall quality of life | Three months post-surgery | |
| Secondary | Health-Related Quality of Life | Health-Related Quality of Life will be assessed with the questionnaire developed by the European Organization for Research and Treatment (EORTC) Quality of Life (QLQ) questionnaire (EORTC QLQ C30). Scores range from 0 to 100 with higher values associated with better overall quality of life | Six months post-surgery | |
| Secondary | Handgrip Strength | Handgrip strength will be determined using an hydraulic dynamometer (Jamar). Both hands will be assessed and the better result out of three attempts will be used. | Pre-Surgery (one week) | |
| Secondary | Handgrip Strength | Handgrip strength will be determined using an hydraulic dynamometer (Jamar). Both hands will be assessed and the better result out of three attempts will be used. | One month post-surgery | |
| Secondary | Handgrip Strength | Handgrip strength will be determined using an hydraulic dynamometer (Jamar). Both hands will be assessed and the better result out of three attempts will be used. | Three months post-surgery | |
| Secondary | Handgrip Strength | Handgrip strength will be determined using an hydraulic dynamometer (Jamar). Both hands will be assessed and the better result out of three attempts will be used. | Six months post-surgery | |
| Secondary | Functional capacity | Functional capacity will be measured with the distance covered by the 6-Minute Walk Test. | Pre-surgery (one week) | |
| Secondary | Functional capacity | Functional capacity will be measured with the distance covered by the 6-Minute Walk Test. | One month post-surgery | |
| Secondary | Functional capacity | Functional capacity will be measured with the distance covered by the 6-Minute Walk Test. | Three months post-surgery | |
| Secondary | Functional capacity | Functional capacity will be measured with the distance covered by the 6-Minute Walk Test. | Six months post-surgery | |
| Secondary | Adherence | Adherence to the scheduled sessions will be registered in the Prehab group and will be reported as percentage of attended vs. scheduled. | Pre-Surgery (one week) | |
| Secondary | Physical Activity | Physical activity levels will be measured using the short form of the International Physical Activity Questionnaire (IPAQ). Estimated METS per week will be calculated based on the available formulas. | Pre-surgery (one week) | |
| Secondary | Physical Activity | Physical activity levels will be measured using the short form of the International Physical Activity Questionnaire (IPAQ). Estimated METS per week will be calculated based on the available formulas. | One month post-surgery | |
| Secondary | Physical Activity | Physical activity levels will be measured using the short form of the International Physical Activity Questionnaire (IPAQ). Estimated METS per week will be calculated based on the available formulas. | Three months post-surgery | |
| Secondary | Physical Activity | Physical activity levels will be measured using the short form of the International Physical Activity Questionnaire (IPAQ). Estimated METS per week will be calculated based on the available formulas. | Six months post-surgery |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04681911 -
Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer
|
Phase 2 | |
| Completed |
NCT04890327 -
Web-based Family History Tool
|
N/A | |
| Terminated |
NCT04066790 -
Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer
|
Phase 2 | |
| Completed |
NCT03591848 -
Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility
|
N/A | |
| Recruiting |
NCT03954197 -
Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients
|
N/A | |
| Terminated |
NCT02202746 -
A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer
|
Phase 2 | |
| Active, not recruiting |
NCT01472094 -
The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
|
||
| Withdrawn |
NCT06057636 -
Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study
|
N/A | |
| Completed |
NCT06049446 -
Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
|
||
| Recruiting |
NCT05560334 -
A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations
|
Phase 2 | |
| Active, not recruiting |
NCT05501769 -
ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer
|
Phase 1 | |
| Recruiting |
NCT04631835 -
Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer
|
Phase 1 | |
| Completed |
NCT04307407 -
Exercise in Breast Cancer Survivors
|
N/A | |
| Recruiting |
NCT03544762 -
Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation
|
Phase 3 | |
| Terminated |
NCT02482389 -
Study of Preoperative Boost Radiotherapy
|
N/A | |
| Enrolling by invitation |
NCT00068003 -
Harvesting Cells for Experimental Cancer Treatments
|
||
| Completed |
NCT00226967 -
Stress, Diurnal Cortisol, and Breast Cancer Survival
|
||
| Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
| Recruiting |
NCT06019325 -
Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy
|
N/A | |
| Recruiting |
NCT06006390 -
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
|
Phase 1/Phase 2 |